Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

Allergan targets Actavis legacy plant in Iceland in cost-cutting move

02-Jul-2015 - Manufacturing operations at an Actavis legacy site in Iceland will cease and products will be transferred out the country from 2016, Allergan has announced.

Hospira's Vizag plant begins sterile production following US FDA approval

02-Jul-2015 - Hospira has begun commercial production at a sterile injectable plant in India hit with several 483 forms after the US FDA deemed the site ‘acceptable.’

GSK investing $60m in greener manufacturing at Singapore amoxicillin plant

01-Jul-2015 - GSK is investing £38m ($60m) in enzymatic manufacturing at an antibiotic facility in Singapore which the firm says is greener and more efficient than traditional approaches.

'Outperform' Perrigo better off without Mylan, says analyst report

30-Jun-2015 - The proposed Perrigo merger with Mylan would be of no benefit to either firm in the “highly competitive” OTC sector, according to financial analysts BMO.

Small-scale will be the next big thing says UK’s CPI

24-Jun-2015 - Small-scale production techs will dominate biopharma says the UK organisation tasked with developing the £20m “biologics factory of the future” and the £38m National Biologics Manufacturing Centre in Darlington.

BIO 2015

Wuxi and University of Pennsylvania partner on vector production

18-Jun-2015 - Contract research organisation WuXi has entered a manufacturing collaboration with the University of Pennsylvania to produce gene therapy vectors.

Dispatches from ACHEMA 2015

Surge in demand keeping packaging industry fragmented say ACHEMA vendors

18-Jun-2015 - The patent cliff and biopharmaceuticals have driven opportunities for pharma packaging companies, which say they are opting to grow through innovation rather than M&A.

Processing sector meets at Achema in Frankfurt

17-Jun-2015 - Too much information to process at the massive Achema tradeshow in Frankfurt this week? in-Pharmatechnologist brings you all the news that matters. (Sorry Dan we aren't going to buy you a Segway - Ed)

News in brief

Debiopharm snaps up FibroTrap sample processing technology

16-Jun-2015 - Debiopharm has acquired Spinomix's FibroTrap sample processing technology for an undisclosed sum.

Ireland backs PAT for next-gen manufacturing

11-Jun-2015 - Irish researchers are using Process Analytical Technology (PAT) to find faster, cheaper pharma manufacturing methods, say the nation’s scientists.

UPDATE - Mylan demands a straightforward answer to whether Teva will make a legally binding exchange offer

Teva to Mylan: We will accomplish our 'strong and serious' takeover proposal

08-Jun-2015 - Teva has refuted accusations of “meddling” with Mylan’s business in the latest chapter of what one analyst says is a far from friendly, if not hostile takeover attempt.

News in brief

AstraZeneca signs onto JV to build $125m manufacturing facility in Algeria

08-Jun-2015 - AstraZeneca has partnered with two Algerian companies, AHT Health and Hasnaoui Finance, to create a joint venture with the aim of building a new $125m manufacturing facility in Algeria.

Mylan to Teva: 'Stop meddling in our affairs'

02-Jun-2015 - Teva has been accused of "playing games" with Mylan by acquiring a 1.35% stake in the generics firm weeks after having a $40bn (EUR36bn) takeover bid snubbed.

Ex-Sanofi site offering manufacturing space for SME pharma in London

01-Jun-2015 - An ex-Sanofi site in the UK has been redeveloped to offer start-up and small pharma access to manufacturing space.

EC competition concerns will not stop $17bn Sigma-Aldrich deal, says Merck

28-May-2015 - Merck KGaA is confident it will close the $17bn acquisition of Sigma-Aldrich in mid-2015 despite competition concerns from the European Commission (EC).

Intertek opens new drug stability testing facility citing demand and bigger med devices

26-May-2015 - Intertek has opened a new stability facility citing demand for bespoke drug and device services like abuse potential assessments and stress testing.

Home-brew morphine: Is opiate production about to get way too easy?

21-May-2015 - Access to yeast strains modified to produce opiates for cheaper, more effective pain meds must be strictly controlled according to researchers who warn that stopping criminals using such API manufacturing routes to make illegal narcotics is vital.

Janssen and Rutgers expand R&D as continuous manufacturing picks up steam

20-May-2015 - Despite pharma being “highly regulated and slow to change,” continuous manufacturing will soon be realised, says Rutgers University which has received an R&D grant from J&J.

Endo buys Par, Lupin enters Brazil... it's been a busy week in generics

19-May-2015 - Endo’s $8bn takeover of Par Pharmaceutical is expected to shake-up the generics sector, while Lupin is expanding its South American network – welcome to In-Pharmatechnologist’s M&A round-up.

Hospira approval puts Pfizer on track to close $17bn deal by year's end

18-May-2015 - Pfizer is set to close its $17bn (€15bn) acquisition by the end of the year after receiving the thumbs up from Hospira shareholders.

Lack of talent will hamper continuous manufacturing adoption, says MIT Prof

13-May-2015 - A lack of scientific talent will hold pharma back from adopting continuous manufacturing despite the imminent opening of regulatory pathways, says an MIT Professor.

Sandoz opens $47m packaging centre to support Polish manufacturing site

11-May-2015 - Novartis subsidiary Sandoz has opened a new packaging facility to support the five billion tablets made at a site in Poland.


Hospira to lay off 100 following closure of Clayton, NC plant

07-May-2015 - Hospira’s closure of its manufacturing facility in Clayton, North Carolina, which it says is a cost rather than a quality issue , will result in the laying off of 100 employees, according to a WARN notice  posted Wednesday.

Three-way collaboration to offer packaging serialisation ahead of EU Directive

06-May-2015 - Schott, Heuft and GEA have teamed up to offer drugmakers a serialisation service for primary packaging to help with EU anti-counterfeiting requirements.

FDA calls on manufacturers to begin switch from batch to continuous production

01-May-2015 - Though making the switch from batch to continuous manufacturing may be difficult, costly and time consuming, pharma manufacturers and CMOs should begin to consider the switch as in the long-run it will end up saving companies time, money and space, FDA’s CDER Director Janet Woodcock told congressmen in a hearing Thursday. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...